Condition
Anterior Blepharitis
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Terminated1
Unknown1
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07856680Phase 4Not Yet RecruitingPrimary
Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study
NCT05160623Not ApplicableUnknownPrimary
Treatment of Blepharitis With Povidone-Iodine 1%
NCT04290455Not ApplicableTerminatedPrimary
Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure
Showing all 3 trials